These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29766990)

  • 1. Correction: Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4.
    Jiang T; Wang F; Hu L; Cheng X; Zheng Y; Liu T; Jia Y
    Oncotarget; 2018 Apr; 9(30):21629. PubMed ID: 29766990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4.
    Jiang T; Wang F; Hu L; Cheng X; Zheng Y; Liu T; Jia Y
    Oncotarget; 2017 Sep; 8(44):77586-77594. PubMed ID: 29100410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway.
    Zhou J; Zhang C; Sui X; Cao S; Tang F; Sun S; Wang S; Chen B
    Invest New Drugs; 2018 Aug; 36(4):571-580. PubMed ID: 29504068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of chidamide on human B lymphoma cell lines and its mechanisms].
    Li YY; Wang YF; Wang J; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):893-9. PubMed ID: 22931650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose decitabine enhances chidamide-induced apoptosis in adult acute lymphoblast leukemia, especially for p16-deleted patients through DNA damage.
    Shi P; Zhang L; Chen K; Jiang Z; Deng M; Zha J; Guo X; Li P; Xu B
    Pharmacogenomics; 2017 Aug; 18(13):1259-1270. PubMed ID: 28745928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabine.
    Hsieh YY; Huang TC; Lo HL; Jhan JY; Chen ST; Yang PM
    Oncotarget; 2018 Aug; 9(64):32402. PubMed ID: 30190797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabine.
    Li X; Yan X; Guo W; Huang X; Huang J; Yu M; Ma Z; Xu Y; Huang S; Li C; Zhou Y; Jin J
    Biomed Pharmacother; 2017 Jun; 90():699-704. PubMed ID: 28419965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes.
    Liu Z; Ding K; Li L; Liu H; Wang Y; Liu C; Fu R
    Biomed Pharmacother; 2016 Oct; 83():1032-1037. PubMed ID: 27541047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in Non-Small-Cell lung cancer cells.
    Zhou Y; Pan DS; Shan S; Zhu JZ; Zhang K; Yue XP; Nie LP; Wan J; Lu XP; Zhang W; Ning ZQ
    Biomed Pharmacother; 2014 May; 68(4):483-91. PubMed ID: 24721323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer.
    Zhao B; He T
    Oncol Rep; 2015 Jan; 33(1):304-10. PubMed ID: 25384499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krüppel-like factor 4 contributes to the pathogenesis of mantle cell lymphoma.
    Li XY; Geng LY; Zhou XX; Wei N; Fang XS; Li Y; Wang X
    Leuk Lymphoma; 2017 Oct; 58(10):2460-2469. PubMed ID: 28278702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decitabine and vitamin D3 differentially affect hematopoietic transcription factors to induce monocytic differentiation.
    Koschmieder S; Agrawal S; Radomska HS; Huettner CS; Tenen DG; Ottmann OG; Berdel WE; Serve HL; Müller-Tidow C
    Int J Oncol; 2007 Feb; 30(2):349-55. PubMed ID: 17203216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylated CD36 gene affected the progression of lung cancer.
    Sun Q; Zhang W; Wang L; Guo F; Song D; Zhang Q; Zhang D; Fan Y; Wang J
    Gene; 2018 Dec; 678():395-406. PubMed ID: 29969695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of chidamide on the growth of human adenoid cystic carcinoma cells.
    Yang S; Nan P; Li C; Lin F; Li H; Wang T; Zhou C; Zhang X; Meng X; Qian H; Wang H; Dong M
    Biomed Pharmacother; 2018 Mar; 99():608-614. PubMed ID: 29710459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy.
    Gritt G; Gianatt A; Petronzeii F; De Santis R; Pavoni C; Rossi RL; Cattaneo L; Spagnoli LG; Ferrar S; Ross A; Barbu AM; Rambald A
    Oncotarget; 2018 Mar; 9(24):17256. PubMed ID: 29683132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganoderma immunomodulatory protein and chidamide down-regulate integrin-related signaling pathway result in migration inhibition and apoptosis induction.
    Lu CT; Leong PY; Hou TY; Huang SJ; Hsiao YP; Ko JL
    Phytomedicine; 2018 Dec; 51():39-47. PubMed ID: 30466626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Predictive biomarkers for disease sensitivity in lymphoma - the holy grail for HDAC inhibitors?
    Eyre TA
    Oncotarget; 2019 Feb; 10(17):1661. PubMed ID: 30899436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
    Li Y; Wang Y; Zhou Y; Li J; Chen K; Zhang L; Deng M; Deng S; Li P; Xu B
    Clin Epigenetics; 2017; 9():83. PubMed ID: 28814980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel.
    McDonald JT; Kritharis A; Beheshti A; Pilichowska M; Burgess K; Ricks-Santi L; McNiel E; London CA; Ravi D; Evens AM
    Oncotarget; 2018 Sep; 9(70):33441. PubMed ID: 30279973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: MiR-124 acts as a target for Alzheimer's disease by regulating BACE1.
    An F; Gong G; Wang Y; Bian M; Yu L; Wei C
    Oncotarget; 2018 May; 9(37):24871. PubMed ID: 29873327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.